Results 151 to 160 of about 8,133 (230)

Cutaneous sarcoidosis successfully treated with PUVA therapy

Przegląd Dermatologiczny
Agata Szczecina, Katarzyna Chyl-Surdacka, Ewelina Dybała, Agnieszka Borzęcka-Sapko, Franciszek Szubstarski, Adam Borzęcki   +5 more
doaj   +1 more source

Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports. [PDF]

Ther Adv Hematol
Bernardelli A, Visco C.
europepmc   +1 more source

Genetic Markers of Methotrexate Treatment Failure in Psoriasis. [PDF]

J Pers Med
Vikhreva MN, Danilov LG, Martynov AA, Levashova OA, Tuchkova SN, Abdullaev SP, Mirzaev KB, Glotov AS, Glotov OS, Sychev DA.   +9 more
europepmc   +1 more source

Long-term Durability of Narrowband Ultraviolet B-induced Repigmentation in Non-segmental Vitiligo: A Retrospective Study. [PDF]

Acta Derm Venereol
Kassem R, Vaynshteyn I, Barzilai A, Handelsman A, Scope A, Schaffer M, Baum S, Pavlotsky F.   +7 more
europepmc   +1 more source

Long-term control of refractory acrodermatitis continua of Hallopeau with subcutaneous spesolimab: A case report. [PDF]

JAAD Case Rep
Wagner JN, Zirkenbach F, Stephan B, Grote C, Augustin M.   +4 more
europepmc   +1 more source

The Evaluation of Skin Infiltration in Mycosis Fungoides/Sézary Syndrome Using the High-Frequency Ultrasonography. [PDF]

J Clin Med
Cisoń H, Jankowska-Konsur A, Białynicki-Birula R.   +2 more
europepmc   +1 more source

Chlormethine gel effectiveness as second-line treatment in mycosis fungoides: a single-centre retrospective study. [PDF]

Discov Oncol
Zengarini C, Guglielmo A, Vocale L, Filippini A, Bardazzi F, Morsia E, Neri I, Mussi M, Piraccini BM, Pileri A.   +9 more
europepmc   +1 more source

S1-Guideline for diagnosis and therapy of necrobiosis lipoidica. [PDF]

J Dtsch Dermatol Ges
Erfurt-Berge C, Renner R, Peckruhn M, Tittelbach J, Terhorst-Molawi D, Kauer F, Dissemond J.   +6 more
europepmc   +1 more source

Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies. [PDF]

Australas J Dermatol
Bettolini L, Maione V, Carugno A, Stabile G, Podo Brunetti A, Fratton Z, Errichetti E, Zerbinati N, Rongioletti F, Calzavara-Pinton P, Rossi M, Bighetti S.   +11 more
europepmc   +1 more source

IQDMA disrupts STAT5 nuclear transport through CDC42-PAK2 axis collapse in cutaneous T-cell lymphoma. [PDF]

Front Immunol
Dey S, Sorger H, Schlederer M, Perchthaler I, Metzelder M, Kenner L, Moriggl R, Wolf P.   +7 more
europepmc   +1 more source